Corvus Pharma Com (CRVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Operating Expenses | 19,297 | 14,877 | 12,217 | 10,572 | 10,260 |
| Operating Income | -19,297 | -14,877 | -12,217 | -10,572 | -10,260 |
| Other Income | 1,338 | 1,185 | -104 | 415 | 2,262 |
| Pre-tax Income | -17,959 | -13,692 | -12,321 | -10,157 | -7,998 |
| Net Income Continuous | -17,959 | -13,692 | -12,321 | -10,157 | -7,998 |
| Net Income | $-17,959 | $-13,692 | $-12,321 | $-10,157 | $-7,998 |
| EPS Basic Total Ops | -0.19 | -0.15 | -0.18 | -0.12 | -0.10 |
| EPS Basic Continuous Ops | -0.19 | -0.15 | -0.18 | -0.12 | -0.10 |
| EPS Diluted Total Ops | -0.19 | -0.15 | -0.18 | -0.12 | -0.10 |
| EPS Diluted Continuous Ops | -0.19 | -0.15 | -0.17 | -0.12 | -0.10 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.15 | -0.15 | -0.12 | -0.10 |
| EBITDA(a) | $-19,078 | $-14,865 | $-12,452 | $-11,003 | $-10,565 |